Archive

2017, Vol. 127, No. 3

March 31, 2017

previous issuenext issue
Editorials
Immune biomarkers: do they impact long-term graft survival?

Jolanta Małyszko, Jacek Małyszko

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 149-151 / DOI: 10.20452/pamw.3988

Long pentraxin PTX3 as a prognostic marker of cardiovascular mortality in patients with chronic kidney disease

Andrea Baragetti, Giuseppe D. Norata

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 152-153 / DOI: 10.20452/pamw.3989

Original articles
Endosonography‑guided fine‑needle aspiration in the diagnosis of sarcoidosis: a randomized study

Piotr Kocoń, Artur Szlubowski, Jarosław Kużdżał, Lucyna Rudnicka-Sosin, Adam Ćmiel, Jerzy Soja, Janusz R. Włodarczyk, Piotr Talar, Tomasz Smęder, Tomasz Gil, Janusz Warmus, Romana Tomaszewska

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 154-162 / DOI: 10.20452/pamw.3934

Expression of ghrelin and ghrelin functional receptor GHSR1a in human pituitary adenomas

Mirosław Andrusiewicz, Hanna Komarowska, Izabela Skibińska, Małgorzata Chmielewska, Magdalena Jaskuła-Świtek, Włodzimierz Liebert, Ryszard Waśko, Małgorzata Kotwicka

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 163-169 / DOI: 10.20452/pamw.3967

Pentraxin 3 as a new indicator of cardiovascular‑related death in patients with advanced chronic kidney disease

Marcin Krzanowski, Katarzyna Krzanowska, Mariusz Gajda, Paulina Dumnicka, Artur Dziewierz, Karolina Woziwodzka, Jan A. Litwin, Władysław Sułowicz

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 170-177 / DOI: 10.20452/pamw.3944

Immune biomarkers and long‑term graft survival: a prospective follow‑up of 457 kidney transplant recipients

Michał Ciszek, Krzysztof Mucha, Bartosz Foroncewicz, Dorota Żochowska, Maciej Kosieradzki, Tadeusz Grochowiecki, Magdalena Durlik, Andrzej Górski, Leszek Pączek

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 178-183 / DOI: 10.20452/pamw.3937

Arterial structure and function in patients with acute coronary syndrome after 1‑year treatment

Agata Schneider, Joanna Gawęcka, Andrzej Minczykowski, Tomasz Krauze, Przemysław Guzik, Jarosław Piskorski, James Heathers, Andrzej Wykrętowicz

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 184-189 / DOI: 10.20452/pamw.3939

Review articles
Recent advances in understanding the clinical relevance of antiplatelet alloantibodies

Katarzyna Guz, Małgorzata Uhrynowska, Izabella Kopeć, Marzena Dębska, Anne Husebekk, Ewa Brojer

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 190-194 / DOI: 10.20452/pamw.3932

Recent advances in the pathophysiology of arterial hypertension: potential implications for clinical practice

Dagmara Hering, Andrzej Trzebski, Krzysztof Narkiewicz

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 195-204 / DOI: 10.20452/pamw.3971

Clinical images
IgG4‑related disease as an unusual cause of biliary stenosis and lymphadenopathy

Magdalena Stojek, Grzegorz Rymkiewicz, Marian Smoczyński, Wojciech Biernat, Krystian Adrych, Jan M. Zaucha

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 212-213 / DOI: 10.20452/pamw.3983

Research letters
Safety and effectiveness of symptomatic hyponatremia treatment according to the European Society of Endocrinology guidelines: a retrospective study

Alina Kuryłowicz, Alicja S. Wesołowska, Anna Wolska, Janusz Pachucki, Tomasz Bednarczuk, Urszula Ambroziak

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 205-208 / DOI: 10.20452/pamw.3984

Hooves better than potatoes: in vitro effects of balanced crystalloid and colloids on functional parameters of coagulation and fibrinolysis

Łukasz J. Krzych, Piotr F. Czempik

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 209-211 / DOI: 10.20452/pamw.3981

Letters to the Editor
Breath holding as a specific type of breathing training from the viewpoint of Avicenna

Narjes Gorji, Reihaneh Moeini, Seyyedali Mozaffarpour, Morteza Mojahedi

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 214-215 / DOI: 10.20452/pamw.3990

Breath holding as a specific type of breathing training from the viewpoint of Avicenna. Authors' reply

Grzegorz Bilo, Gianfranco Parati, Kalina Kawecka-Jaszcz

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 215-215 / DOI: 10.20452/pamw.3991

Angiotensin receptor neprilysin inhibitor treatment is safe and potentially efficacious in end‑stage hypertrophic cardiomyopathy

Paweł Rubiś, Sylwia Wiśniowska‑Śmiałek, Katarzyna Holcman, Agata Leśniak‑Sobelga, Magdalena Kostkiewicz, Piotr Podolec

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 216-218 / DOI: 10.20452/pamw.3982

Clinical practice interviews
Treatment of hypertension: choosing the first‑line treatment. Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 1

Franz H. Messerli, Roman Jaeschke

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 219-220 / DOI: 10.20452/pamw.3992

Treatment of hypertension: When to start? What is the target? Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 2

Franz H. Messerli, Roman Jaeschke

Pol Arch Intern Med. 2017, Vol. 127, No. 3: 221-222 / DOI: 10.20452/pamw.3993

Impact Factor 2022

4.8

IC value for 2022

217.18

Ministry of Education and Science score

200
Average times from:
submission to 1st decision, 2 days
submission to first reviews, 23 days
acceptance to online first publication, 7 days
acceptance to final publication, 91 days

Current manuscript acceptance rate: 28%
The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more